The/DT
RAR-RXR/JJ
as/RB
well/RB
as/IN
the/DT
RXR-RXR/JJ
pathway/NN
is/VBZ
involved/VBN
in/IN
signaling/NN
growth/NN
inhibition/NN
of/IN
human/JJ
CD34+/JJ
erythroid/JJ
progenitor/NN
cells/NNS
./.

Previous/JJ
studies/NNS
have/VBP
shown/VBN
that/IN
retinoic/JJ
acid/NN
(/(
RA/NN
)/)
,/,
similar/JJ
to/TO
tumor/NN
necrosis/NN
factor-alpha/NN
(/(
TNF-alpha/NN
)/)
,/,
can/MD
act/VB
as/IN
a/DT
bifunctional/JJ
regulator/NN
of/IN
the/DT
growth/NN
of/IN
bone/NN
marrow/NN
progenitors/NNS
,/,
in/IN
that/IN
it/PRP
can/MD
stimulate/VB
granulocyte-macrophage/JJ
colony-stimulating/JJ
factor/NN
(/(
GM-CSF/NN
)/)
-/:
or/CC
interleukin-3/NN
(/(
IL-3/NN
)/)
-induced/JJ
GM/NN
colony/NN
formation/NN
,/,
but/CC
potently/RB
inhibit/VBP
G-CSF-induced/JJ
growth/NN
./.
=====
The/DT
present/JJ
study/NN
,/,
using/VBG
highly/RB
enriched/VBN
human/JJ
CD34+/JJ
as/RB
well/RB
as/IN
Lin- murine/JJ
bone/NN
marrow/NN
progenitor/NN
cells/NNS
,/,
demonstrates/VBZ
a/DT
potent/JJ
inhibitory/JJ
effect/NN
of/IN
9-cis-RA/NN
on/IN
burst-forming/JJ
unit-erythroid/JJ
(/(
BFU-E/NN
)/)
colony/NN
formation/NN
regardless/RB
of/IN
the/DT
cytokine/NN
stimulating/NN
growth/NN
./.
=====
Specifically/RB
,/,
9-cis-RA/NN
potently/RB
inhibited/VBD
the/DT
growth/NN
of/IN
BFU-E/NN
response/NN
to/TO
erythropoietin/NN
(/(
Epo/NN
)/)
(/(
100/CD
%/NN
)/)
,/,
stem/NN
cell/NN
factor/NN
(/(
SCF/NN
)/)
+/CC
Epo/NN
(/(
92/CD
%/NN
)/)
,/,
IL-3/NN
+/CC
Epo/NN
(/(
97/CD
%/NN
)/)
,/,
IL-4/NN
+/CC
Epo/NN
(/(
88/CD
%/NN
)/)
,/,
and/CC
IL-9/NN
+/CC
Epo/NN
(/(
100/CD
%/NN
)/)
./.
=====
Erythroid/JJ
colony/NN
growth/NN
was/VBD
also/RB
inhibited/VBN
when/WRB
CD34+/JJ
progenitors/NNS
were/VBD
seeded/VBN
at/IN
one/CD
cell/NN
per/IN
well/NN
,/,
suggesting/VBG
a/DT
direct/JJ
action/NN
of/IN
RA/NN
./.
=====
Using/VBG
synthetic/JJ
ligands/NNS
to/TO
retinoic/JJ
acid/NN
receptors/NNS
(/(
RARs/NNS
)/)
and/CC
retinoid/NN
X/NN
receptors/NNS
(/(
RXRs/NNS
)/)
that/WDT
selectively/RB
bind/VBP
and/CC
activate/VBP
RAR-RXR/NN
or/CC
RXR-RXR/JJ
dimers/NNS
,/,
respectively/RB
,/,
we/PRP
dissected/VBD
the/DT
involvement/NN
of/IN
the/DT
two/CD
retinoid/NN
response/NN
pathways/NNS
in/IN
the/DT
regulation/NN
of/IN
normal/JJ
myeloid/JJ
and/CC
erythroid/JJ
progenitor/NN
cell/NN
growth/NN
./.
=====
Transactivation/NN
studies/NNS
showed/VBD
that/IN
both/CC
the/DT
RAR/NN
(/(
Ro/NN
13-7410/CD
)/)
and/CC
RXR/NN
(/(
Ro/NN
25-6603/CD
and/CC
Ro/NN
25-7386/CD
)/)
ligands/NNS
were/VBD
highly/RB
selective/JJ
at/IN
100/CD
nmol/L/NN
./.
=====
At/IN
this/DT
concentration/NN
,/,
Ro/NN
13-7410/CD
potently/RB
inhibited/VBD
G-CSF-stimulated/JJ
myeloid/JJ
as/RB
well/RB
as/IN
SCF/NN
+/CC
Epo-induced/JJ
erythroid/JJ
colony/NN
growth/NN
./.
=====
At/IN
the/DT
same/JJ
concentration/NN
,/,
Ro/NN
25-6603/CD
and/CC
Ro/NN
25-7386/CD
had/VBD
little/JJ
or/CC
no/DT
effect/NN
on/IN
G-CSF-induced/JJ
colony/NN
formation/NN
,/,
whereas/IN
they/PRP
inhibited/VBD
75/CD
%/NN
and/CC
53/CD
%/NN
,/,
respectively/RB
,/,
of/IN
SCF/NN
+/CC
Epo-stimulated/JJ
BFU-E/NN
colony/NN
growth/NN
./.
=====
Thus/RB
,/,
the/DT
RAR-RXR/JJ
response/NN
pathway/NN
can/MD
signal/VB
growth/NN
inhibition/NN
of/IN
normal/JJ
bone/NN
marrow/NN
myeloid/JJ
and/CC
erythroid/JJ
progenitor/NN
cells/NNS
./.
=====
In/IN
addition/NN
,/,
we/PRP
demonstrate/VBP
a/DT
unique/JJ
involvement/NN
of/IN
the/DT
RXR-RXR/JJ
pathway/NN
in/IN
mediating/VBG
growth/NN
inhibition/NN
of/IN
erythroid/JJ
but/CC
not/RB
myeloid/JJ
progenitor/NN
cells/NNS
./.